BCDA
Biocardia IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$12.36M
P/E Ratio
—
EPS
$-1.25
Beta
0.55
52W High
$2.92
52W Low
$1.00
50-Day MA
$1.20
200-Day MA
$1.44
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About Biocardia Inc
BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapies for cardiovascular disease. The company is headquartered in San Carlos, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-4.96M |
| EBITDA | $-8.25M |
| Operating Margin | 0.00% |
| Return on Equity | -950.00% |
| Return on Assets | -145.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.08 |
| Price-to-Book | 13.57 |
| Price-to-Sales (TTM) | 1985.81 |
| EV/Revenue | 3111.7 |
| EV/EBITDA | -3.16 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $10.94M |
| Float | $8.34M |
| % Insiders | 31.12% |
| % Institutions | 6.89% |
Historical Volatility
HV 10-Day
38.33%
HV 20-Day
38.76%
HV 30-Day
38.33%
HV 60-Day
45.73%
HV Rank
3.6%
Volatility is currently expanding
Analyst Ratings
Consensus ($15.50 target)
2
BuyMore HEALTHCARE Stocks
Data last updated: 5/5/2026